Near-total human face transplantation for a severely disfigured patient in the USA
- PMID: 19608265
- DOI: 10.1016/S0140-6736(09)61155-7
Near-total human face transplantation for a severely disfigured patient in the USA
Abstract
Background: Multiple reconstructive procedures are common for the reconstruction of complex facial deformities of skin, soft tissues, bony structures, and functional subunits, such as the nose, lips, and eyelids. However, the results have been unsatisfactory. An innovative approach entailing a single surgical procedure of face allograft transplantation is a viable alternative and gives improved results.
Methods: On Dec 9, 2008, a 45-year-old woman with a history of severe midface trauma underwent near-total face transplantation in which 80% of her face was replaced with a tailored composite tissue allograft. We addressed issues of immunosuppressive therapy, psychological and ethical outcomes, and re-integration of the patient into society.
Findings: After the operation, the patient did well physically and psychologically, and tolerated immunosuppression without any major complication. Routine biopsy on day 47 after transplantation showed rejection of graft mucosa; however, a single bolus of corticosteroids reversed rejection. During the first 3 weeks after transplantation, the patient accepted her new face; 6 months after surgery, the functional outcome has been excellent. In contrast to her status before transplantation, the patient can now breathe through her nose, smell, taste, speak intelligibly, eat solid foods, and drink from a cup.
Interpretation: We show the feasibility of reconstruction of severely disfigured patients in a single surgical procedure using composite face allotransplantation. Therefore, this should be taken in consideration as an early option for severely disfigured patients.
Funding: None.
Comment in
-
Facial transplantation: lessons so far.Lancet. 2009 Jul 18;374(9685):177-8. doi: 10.1016/S0140-6736(09)61292-7. Epub 2009 Jul 14. Lancet. 2009. PMID: 19608266 No abstract available.
Similar articles
-
First U.S. near-total human face transplantation: a paradigm shift for massive complex injuries.Plast Reconstr Surg. 2010 Jan;125(1):111-122. doi: 10.1097/PRS.0b013e3181c15c4c. Plast Reconstr Surg. 2010. PMID: 19770815
-
Facial Transplantation.Facial Plast Surg Clin North Am. 2016 Aug;24(3):367-77. doi: 10.1016/j.fsc.2016.03.013. Facial Plast Surg Clin North Am. 2016. PMID: 27400850 Review.
-
Facial transplantation.Curr Opin Otolaryngol Head Neck Surg. 2012 Aug;20(4):291-7. doi: 10.1097/MOO.0b013e3283552cc5. Curr Opin Otolaryngol Head Neck Surg. 2012. PMID: 22894997 Review.
-
Supporting facial transplantation with the pillars of bioethics.J Reconstr Microsurg. 2010 Oct;26(8):547-54. doi: 10.1055/s-0030-1262949. Epub 2010 Aug 3. J Reconstr Microsurg. 2010. PMID: 20683814 Review.
-
Human facial allotransplantation: a 2-year follow-up study.Lancet. 2008 Aug 23;372(9639):631-8. doi: 10.1016/S0140-6736(08)61276-3. Lancet. 2008. PMID: 18722867
Cited by
-
Anaesthetic Management for Face Transplantations: The Experience of Akdeniz University.Turk J Anaesthesiol Reanim. 2019 Jun;47(3):228-334. doi: 10.5152/TJAR.2019.04935. Epub 2019 Jan 18. Turk J Anaesthesiol Reanim. 2019. PMID: 31183470 Free PMC article.
-
Establishing cephalometric landmarks for the translational study of Le Fort-based facial transplantation in Swine: enhanced applications using computer-assisted surgery and custom cutting guides.Plast Reconstr Surg. 2014 May;133(5):1138-1151. doi: 10.1097/PRS.0000000000000110. Plast Reconstr Surg. 2014. PMID: 24445879 Free PMC article.
-
A biodegradable microvessel scaffold as a framework to enable vascular support of engineered tissues.Biomaterials. 2013 Dec;34(38):10007-15. doi: 10.1016/j.biomaterials.2013.09.039. Epub 2013 Sep 27. Biomaterials. 2013. PMID: 24079890 Free PMC article.
-
Recovery of facial expressions using functional electrical stimulation after full-face transplantation.J Neuroeng Rehabil. 2018 Mar 6;15(1):15. doi: 10.1186/s12984-018-0356-0. J Neuroeng Rehabil. 2018. PMID: 29510722 Free PMC article.
-
Human dystrophin expressing chimeric (DEC) cell therapy ameliorates cardiac, respiratory, and skeletal muscle's function in Duchenne muscular dystrophy.Stem Cells Transl Med. 2021 Oct;10(10):1406-1418. doi: 10.1002/sctm.21-0054. Epub 2021 Jul 22. Stem Cells Transl Med. 2021. PMID: 34291884 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials